Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | -4.00% |
|
-2.04% | -22.58% |
Jul. 02 | Innocan Pharma Engages Pain-Management Expert Ahead of FDA Meeting | MT |
Jun. 11 | Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-22.58% | 51.55M | |
+56.98% | 809B | |
+39.52% | 624B | |
-6.90% | 351B | |
+7.45% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.79% | 166B | |
-2.85% | 157B |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain